Concise review: Pursuing self-renewal and pluripotency with the stem cell factor Nanog

Stem Cells

Volumn 31, Issue 7, 2013, Pages 1227-1236

  Saunders, Arven ^a   Faiola, Francesco ^a   Wang, Jianlong ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Embryonic stem cells; Induced pluripotent stem cells; Nanog; Pluripotency; Reprogramming; Self renewal

Indexed keywords

DIMER; GLYCOGEN SYNTHASE KINASE 3; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ACETYLATION; ALLELE; AMBYSTOMA; ARTICLE; BLASTOCYST; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL REGENERATION; CELL RENEWAL; CELL SURVIVAL; CELL TYPE; CHICK; DIMERIZATION; DNA METHYLATION; DNA MODIFICATION; EMBRYONIC STEM CELL; EVOLUTIONARY DEVELOPMENTAL BIOLOGY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE LOCUS; GENE REPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; IN VIVO STUDY; NONHUMAN; OPEN READING FRAME; ORTHOLOGY; PLURIPOTENT STEM CELL; PREIMPLANTATION EMBRYO; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEOMICS; PSEUDOGENE; SALAMANDER; SEQUENCE ALIGNMENT; SOMATIC CELL; SUMOYLATION; UBIQUITINATION; ZEBRA FISH;

EMBRYONIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; NANOG; PLURIPOTENCY; REPROGRAMMING; SELF-RENEWAL;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; PLURIPOTENT STEM CELLS;

AMBYSTOMA MEXICANUM; DANIO RERIO; SALAMANDROIDEA; VERTEBRATA;

EID: 84879898108     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1384     Document Type: Article

References (92)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
2. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981;78:7634-7638.
3. Nichols J, Smith A. Naive and primed pluripotent states. Stem Cells 2009;4:487-492.
4. Ying Q-L, Wray J, Nichols J et al. The ground state of embryonic stem cell self-renewal. Nature 2008;453:519-523.
5. Tesar PJ, Chenoweth JG, Brook FA et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007;448:196-199.
6. Smith AG, Heath JK, Donaldson DD et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988;336:688-690.
7. Williams RL, Hilton DJ, Pease S et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988;336:684-687.
8. Ying Q-L, Nichols J, Chambers I et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell selfrenewal in collaboration with STAT3.Cell 2003;115:281-292.
9. Mitsui K, Tokuzawa Y, Itoh H et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003;113:631-642.
10. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956.
11. Thomson J, Itskovitz-Eldor J, Shapiro S. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
12. Bradley A, Evans M, Kaufman MH et al. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984; 309:255-256.
13. Tilgner K, Atkinson SP, Golebiewska A et al. Isolation of primordial germ cells from differentiating human embryonic stem cells. Stem Cells 2008;26:3075-3085.
14. Geijsen N, Horoschak M, Kim K et al. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 2004;427: 148-154.
15. Brons IGM, Smithers LE, Trotter MWB et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007;448: 191-195.
16. Najm FJ, Chenoweth JG, Anderson PD et al. Isolation of epiblast stem cells from preimplantation mouse embryos. Stem Cells 2011;8: 318-325.
17. Silva J, Barrandon O, Nichols J, et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 2008;6: e253.
18. Vallier L. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 2005;118: 4495-4509.
19. Bendall SC, Stewart MH, Menendez P et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007;448:1015-1021.
20. Niwa H, Ogawa K, Shimosato D et al. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 2009;460:118-122.
21. Vallier L, Mendjan S, Brown S et al. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 2009;136:1339-1349.
22. Booth HAF, Holland PWH. Eleven daughters of NANOG. Genomics 2004;84:229-238.
23. Zhang J, Wang X, Li M et al. NANOGP8 is a retrogene expressed in cancers. FEBS J 2006;273:1723-1730.
24. Robertson M, Stenhouse F, Colby D et al. Nanog retrotransposed genes with functionally conserved open reading frames. Mamm Genome 2006;17:732-743.
25. Das S, Jena S, Levasseur DN. Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells. J Biol Chem 2011;286:42690-42703.
26. Pritsker M, Doniger TT, Kramer LC et al. Diversification of stem cell molecular repertoire by alternative splicing. Proc Natl Acad Sci USA 2005;102:14290-14295.
27. Salomonis N, Schlieve CR, Pereira L et al. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc Natl Acad Sci USA 2010;107:10514-10519.
28. Gu B, Zhu W-G. Surf the post-translational modification network of p53 regulation. Int J Biol Sci 2012;8:672-684.
29. Yates A, Chambers I. The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells. Biochem Soc Trans 2005;33(Pt 6):1518-1521.
30. Hornbeck PV, Kornhauser JM, Tkachev S et al. PhosphoSitePlus: A comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 40(Database issue):D261-270.
31. Moretto-Zita M, Jin H, Shen Z et al. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc Natl Acad Sci USA 2010;107:13312- 13317.
32. Ho B, Olson G, Figel S et al. Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated. J Biol Chem 2012;287:18656-18673.
33. Bourguignon LYW, Spevak CC, Wong G et al. Hyaluronan-CD44 interaction with protein kinase C promotes oncogenic signaling by the stem cell marker nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 2009;284:26533-26546.
34. Ramakrishna S, Suresh B, Lim K-H et al. PEST motif sequence regulating human NANOG for proteasomal degradation. Stem Cells Dev 2011;20:1511-1519.
35. Buckley SM, Aranda-Orgilles B, Strikoudis A et al. Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system. Cell Stem Cell 2012;11:783-798.
36. Chambers I, Colby D, Robertson M et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003;113:643-655.
37. Rossant J, Tam PPL. Blastocyst lineage formation, early embryonic asymmetries and axis patterning in the mouse. Development 2009; 136:701-713.
38. Wang J, Rao S, Chu J et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006;444:364-368.
39. Wang J, Levasseur DN, Orkin SH. Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA 2008;105:6326-6331.
40. Mullin NP, Yates A, Rowe AJ et al. The pluripotency rheostat Nanog functions as a dimer. Biochem J 2008;411:227-231.
41. Fidalgo M, Shekar PC, Ang Y-S et al. Zfp281 functions as a transcriptional repressor for pluripotency of mouse embryonic stem cells. Stem Cells 2011;29:1705-1716.
42. Kim J, Chu J, Shen X et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008;132:1049-1061.
43. Wang Z-X, Teh CH-L, Chan CM-Y et al. The transcription factor Zfp281 controls embryonic stem cell pluripotency by direct activation and repression of target genes. Stem Cells 2008;26:2791-2799.
44. Schuff M, Siegel D, Philipp M et al. Characterization of Danio rerio Nanog and functional comparison to xenopus vents. Stem Cells Dev 2012;21:1225-1238.
45. Theunissen TW, Costa Y, Radzisheuskaya A et al. Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain. Development 2011;138:4853-4865.
46. Dixon JE, Allegrucci C, Redwood C et al. Axolotl Nanog activity in mouse embryonic stem cells demonstrates that ground state pluripotency is conserved from urodele amphibians to mammals. Development 2010;137:2973-2980.
47. Chang DF, Tsai SC, Wang XC et al. Molecular characterization of the human NANOG protein. Stem Cells 2009;27:812-821.
48. Jauch R, Ng CKL, Saikatendu KS et al. Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. J Mol Biol 2008;376:758-770.
49. MacArthur BD, Sevilla A, Lenz M et al. Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. Nat Cell Biol 2012;14:1139-1147.
50. Liang J, Wan M, Zhang Y et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol 2008;10:731-739.
51. Fidalgo M, Faiola F, Pereira C-F et al. Zfp281 mediates Nanog autorepression through recruitment of the NuRD complex and inhibits somatic cell reprogramming. Proc Natl Acad Sci USA 2012;109: 16202-16207.
52. Navarro P, Festuccia N, Colby D et al. OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells. EMBO J 2012;31:1-16.
53. Chen X, Fang F, Liou Y-C et al. Zfp143 regulates Nanog through modulation of Oct4 binding. Stem Cells 2008;26:2759-2767.
54. Rodda DJ. Transcriptional regulation of nanog by OCT4 and SOX2.J Biol Chem 2005;280:24731-24737.
55. Kuroda T, Tada M, Kubota H et al. Octamer and Sox elements are required for transcriptional cis regulation of nanog gene expression. Mol Cell Biol 2005;25:2475-2485.
56. van den Berg DLC, Zhang W, Yates A et al. Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol Cell Biol 2008;28:5986-5995.
57. Schaniel C, Ang Y-S, Ratnakumar K et al. Smarcc1/Baf155 couples self-renewal gene repression with changes in chromatin structure in mouse embryonic stem cells. Stem Cells 2009;27:2979-2991.
58. Ang Y-S, Tsai S-Y, Lee D-F et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 2011;145:183-197.
59. Baltus GA, Kowalski MP, Tutter AV et al. A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2.J Biol Chem 2009;284:6998-7006.
60. Zhang P, Andrianakos R, Yang Y et al. Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J Biol Chem 2010;285:9180-9189.
61. Chan KK-K, Zhang J, Chia N-Y et al. KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells. Stem Cells 2009;27:2114-2125.
62. Cole MF, Johnstone SE, Newman JJ et al. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev 2008;22:746-755.
63. Festuccia N, Osorno R, Halbritter F et al. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012;11:477-490.
64. Martello G, Sugimoto T, Diamanti E et al. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 2012;11:491-504.
65. Percharde M, Lavial F, Ng J-H et al. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev 2012;26:2286-2298.
66. Wu Z, Yang M, Liu H et al. Role of nuclear receptor coactivator 3 (ncoa3) in pluripotency maintenance. J Biol Chem 2012;287: 38295-38304.
67. Lim LS, Hong FH, Kunarso G et al. The pluripotency regulator Zic3 is a direct activator of the Nanog promoter in ESCs. Stem Cells 2010; 28:1961-1969.
68. Chen L, Yabuuchi A, Eminli S et al. Cross-regulation of the Nanog and Cdx2 promoters. Cell Res 2009;19:1052-1061.
69. Gu P, LeMenuet D, Chung AC-K et al. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol 2005;25:8507-8519.
70. Wu DY, Yao Z. Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. Cell Res 2006;16:319-322.
71. Abujarour R, Efe J, Ding S. Genome-wide gain-of-function screen identifies novel regulators of pluripotency. Stem Cells 2010;28: 1487-1497.
72. Suzuki A, Raya A, Kawakami Y et al. Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci USA 2006;103:10294-10299.
73. Lin T, Chao C, Saito S et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005;7:165-171.
74. Li X, Li L, Pandey R et al. The histone acetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptional network. Cell Stem Cell 2012;11:163-178.
75. Villasante A, Piazzolla D, Li H et al. Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells. Cell Cycle 2011;10: 1488-1498.
76. Savarese F, Davila A, Nechanitzky R et al. Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression. Genes Dev 2009;23:2625-2638.
77. Miyanari Y, Torres-Padilla M-E. Control of ground-state pluripotency by allelic regulation of Nanog. Nature 2012;483:470-473.
78. Chambers I, Silva J, Colby D et al. Nanog safeguards pluripotency and mediates germline development. Nature 2007;450:1230-1234.
79. Pereira L, Yi F, Merrill BJ. Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. Mol Cell Biol 2006; 26:7479-7491.
80. Santostefano KE, Hamazaki T, Pardo CE et al. Fibroblast growth factor receptor 2 homodimerization rapidly reduces transcription of the pluripotency gene nanog without dissociation of activating transcription factors. J Biol Chem 2012;287:30507-30517.
81. Luo Y, Lim CL, Nichols J et al. Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. J R Soc Interface 2013;10:20120525.
82. Xu R-H, Sampsell-Barron TL, Gu F et al. NANOG is a direct target of TGFb/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008;3:196-206.
83. Galvin-Burgess KE, Travis ED, Pierson KE et al. TGF-beta-superfamily signaling regulates embryonic stem cell heterogeneity: Self-renewal as a dynamic and regulated equilibrium. Stem Cells 2013;31:48-58.
84. Silva J, Smith A. Capturing pluripotency. Cell 2008;132:532-536.
85. Niwa H. How is pluripotency determined and maintained? Development 2007;134:635-646.
86. Singh AM, Hamazaki T, Hankowski KE et al. A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells 2007;25:2534-2542.
87. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
88. Hanna J, Saha K, Pando B et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009;462:595-601.
89. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
90. Silva J, Chambers I, Pollard S et al. Nanog promotes transfer of pluripotency after cell fusion. Nature 2006;441:997-1001.
91. Silva J, Nichols J, Theunissen TW et al. Nanog is the gateway to the pluripotent ground state. Cell 2009;138:722-737.
92. Costa Y, Ding J, Theunissen TW et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 2013;495:370-374.